Medical Schools Push Back on ‘March-In’ Rights Plan to Lower Drug Prices
Key stakeholders from academia and medicine are pushing back on a Biden administration proposal that would leverage “march-in rights” in an effort to rein in unreasonably priced drugs developed with the support of taxpayer dollars. In a letter sent last week to the National Institute of Standards and Technology (NIST) — the authors of the […]
CMS Revamps Direct Contracting Model
In response to feedback from stakeholders, the Centers for Medicare & Medicaid Services (CMS) announced on Thursday that it will cancel one direct contracting accountable care organization (ACO) model and replace a second direct contacting model with a redesigned version focused on improving health equity for patients. Stakeholder groups shared clashing responses to the new […]